The Chargers designated Apple (hamstring) to return from injured reserve Wednesday, Aaron Wilson of KPRC 2 Houston reports. Apple suffered a hamstring injury during the Chargers' Week 12 loss to ...

The Chargers activated Apple (hamstring) from IR on Friday. Apple remains officially listed as questionable for Saturday's road AFC wild-card matchup against the Texans, but his activation from IR ...

Los Angeles announced receiver Simi Fehoko and cornerback Eli Apple have been activated to the 53-man roster off of injured reserve. Fehoko is back after dealing with an elbow injury and Apple had a ...

Eli Health's Hormometer turns an iPhone into a real-time hormone analyzer, offering insights into your hormone levels using your saliva. Apple's ecosystem can do a lot of health tracking ...

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

In the case of Eli Manning, you cannot. And while Peyton’s overall career might be better, Eli got a leg up on older brother when he won his second Super Bowl MVP following the 2011 season ...

The Los Angeles Chargers designated CB Eli Apple to return from injured reserve on Wednesday, per Kris Rhim. This officially opens Apple’s 21-day window to practice before being activated.

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on ... with Lilly holding a minority equity interest. Sign up here. Apple shares rose more than 3% in premarket trading on Friday after ...

Every year, a new list of players is inducted, and this time, there are 15 finalists left, including former New York Giants quarterback Eli Manning, who is attempting to make it in his first year ...

Eli Lilly spooked the market with warnings of a small revenue slowdown in Q4 2024. Lilly nevertheless delivered good news about its prospects for sales growth in 2025. The company also dropped a ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...

Shares of Eli Lilly (NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024. The pharmaceutical giant expects only $13.5 ...